Neo Ivy Capital Management

Position in VCYT — Veracyte, Inc.

CIK 1727783 NEW YORK, NY

Position in VCYT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$400,656

+$344,218 QoQ

Shares Held

6,822

+315.0% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#226

of 367 holders

Holding Since

Dec 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Neo Ivy Capital Management holds $2,509,451 across 5 Diagnostics & Research names. VCYT ranks #2 (16.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ILMN	Illumina, Inc.	9,690	$1,703,792
2	VCYT	Veracyte, Inc. This page	6,822	$400,656
3	IQV	Iqvia Holdings Inc.	1,879	$363,060
4	DGX	Quest Diagnostics Inc	191	$40,482
5	A	Agilent Technologies, Inc.	11	$1,461

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$400,656	6,822	+315.0%	Shares	Sole	2026-08-14
2025-09-30	$56,438	1,644	-71.8%	Shares	Sole	2025-11-12
2025-03-31	$173,096	5,838	-75.8%	Shares	Sole	2025-05-06
2024-09-30	$820,908	24,116	+1359.8%	Shares	Sole	2024-11-18
2022-03-31	$45,545	1,652	+134.0%	Shares	Sole	2022-05-16
2021-12-31	$29,087	706	-81.1%	Shares	Sole	2022-02-15
2021-06-30	$149,565	3,741	+503.4%	Shares	Sole	2021-08-16
2021-03-31	$33,325	620	-84.4%	Shares	Sole	2021-10-07
2020-12-31	$194,928	3,983	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.